Capstone Investment Advisors LLC Acquires Shares of 7,426 Globe Life Inc. $GL

Capstone Investment Advisors LLC bought a new stake in shares of Globe Life Inc. (NYSE:GL) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund bought 7,426 shares of the company’s stock, valued at approximately $1,327,000.

A number of other large investors also recently made changes to their positions in GL. Hilton Head Capital Partners LLC acquired a new stake in shares of Globe Life during the fourth quarter worth $30,000. Johnson Financial Group Inc. bought a new stake in Globe Life in the second quarter valued at about $39,000. CYBER HORNET ETFs LLC acquired a new position in Globe Life in the second quarter valued at about $28,000. MUFG Securities EMEA plc acquired a new position in Globe Life in the second quarter valued at about $31,000. Finally, Torren Management LLC bought a new position in Globe Life during the fourth quarter worth about $37,000. Institutional investors and hedge funds own 81.61% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Morgan Stanley boosted their target price on Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. Jefferies Financial Group lifted their price objective on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research note on Friday, July 10th. Wells Fargo & Company boosted their price objective on shares of Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a report on Thursday, July 9th. Piper Sandler upped their target price on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. Finally, JPMorgan Chase & Co. increased their target price on shares of Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a report on Tuesday, July 21st. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $191.67.

Insider Buying and Selling

In other news, CEO Frank M. Svoboda sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $166.68, for a total value of $1,666,800.00. Following the completion of the transaction, the chief executive officer owned 54,020 shares in the company, valued at $9,004,053.60. This represents a 15.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO James Matthew Darden sold 50,000 shares of the stock in a transaction on Friday, July 31st. The stock was sold at an average price of $182.43, for a total transaction of $9,121,500.00. Following the sale, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at $10,663,215.93. This represents a 46.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 151,908 shares of company stock valued at $27,239,981. 2.11% of the stock is owned by corporate insiders.

Globe Life Stock Up 0.1%

Shares of Globe Life stock opened at $175.78 on Friday. The company has a market capitalization of $13.51 billion, a P/E ratio of 11.67 and a beta of 0.48. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.07 and a quick ratio of 0.07. The business has a 50-day moving average of $178.72 and a two-hundred day moving average of $159.43. Globe Life Inc. has a 1 year low of $127.85 and a 1 year high of $191.55.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a net margin of 19.58% and a return on equity of 20.52%. The business had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter last year, the firm earned $3.05 EPS. The company’s revenue for the quarter was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, equities analysts predict that Globe Life Inc. will post 15.71 EPS for the current year.

Globe Life Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be paid a $0.33 dividend. The ex-dividend date of this dividend is Monday, October 5th. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. Globe Life’s payout ratio is presently 8.76%.

Globe Life announced that its board has initiated a stock buyback plan on Monday, August 10th that permits the company to repurchase $2.50 billion in outstanding shares. This repurchase authorization permits the company to reacquire up to 17.7% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.